ASCELIA
LIVE

Serial Number

79436062

Owner

Ascelia Pharma AB

Attorney

Monica Riva Talley

Filing Date

Oct 9, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ASCELIA Trademark

Serial Number: 79436062

ASCELIA is a trademark filed by Ascelia Pharma AB on October 9, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Ascelia Pharma AB (5 trademarks)

Per Albin Hanssons väg 41

Entity Type: 03

Trademark Details

Filing Date

October 9, 2025

Registration Date

Not Registered

Goods & Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals; advisory and consulting services relating to medical and diagnostic products in medical and medical diagnostic examination; advisory and consulting services relating to use of contrast medical and contrast agents in medical and diagnostic examinations; advisory and consulting services relating to the use of medical diagnostic imaging and medical imaging technologies; consulting services in the field of diagnostic medical testing

Chemicals used in industry and science; chemical substances and chemical products for scientific purposes, namely, chemical products for diagnostic, chemical preparations, biological research, and pharmaceutical research and adjacent scientific purposes; biochemicals for in vitro and in vivo scientific use; chemicals for use in vitro scientific use

Scientific and technological services, namely, research and design relating thereto in the field of pharmaceuticals and medical imaging; industrial analysis and research services in the field of pharmaceuticals and medical imaging; design and development of computer hardware and software; bacterological and biological research; scientific research in the nature of conducting clinical trials for others; research and development of new products for others; scientific laboratory services

Pharmaceuticals, medical and veterinary preparations, namely, preparations for the prevention, diagnosis, treatment, or management of medical conditions within oncology, immunology, hematology, cardiovascular, neurological, metabolic diseases and adjacent therapeutic areas including diagnostic agents, diagnostic reagents, contrast media, and contrast agents for use in medical diagnostic imaging; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use, food for babies; dietary supplements for humans and animals; medical plasters, being materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; contrast media and contrast agents for use for in vivo imaging; contrast media and contrast agents for use for in vitro diagnostics

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 29, 2026 TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 29, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 28, 2026 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 28, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 28, 2026 TROA
REFUSAL PROCESSED BY IB
Apr 23, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 30, 2026 RFCS
REFUSAL PROCESSED BY MPU
Mar 30, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 28, 2026 RFCR
NON-FINAL ACTION WRITTEN
Feb 27, 2026 CNRT
ASSIGNED TO EXAMINER
Feb 26, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 4, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 4, 2025 NWOS
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Oct 30, 2025 SDRC